$IPIX

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Highlights Preclinical Data by Independent Cancer Researchers Supporting p53 Drug Candidate Kevetrin’s Potential in Treating Acute Myeloid Leukemia 2 weeks, 1 day ago

$IPIX

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Partnering Provides Momentum For Inflammatory Bowel Disease Programs, Targeting a Substantial and Prized Market with a Large Unmet Patient Need 4 weeks, 1 day ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Cites Recent Academic Literature Showing Host Defense Proteins at Cutting-Edge of Medicine for Multiple Diseases 1 month ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Clinical Trial of Oral Brilacidin in Ulcerative Colitis Program Expected to Commence in December; Top-Line Data in Q1 2020 1 month, 1 week ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Engages Locust Walk, A Global Life Sciences Transaction Firm 1 month, 1 week ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Provides Corporate Update Highlighting Clinical Pipeline Progress and Business Development Activities 3 months, 2 weeks ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis 3 months, 3 weeks ago

Robot wrote a new post, $IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease 5 months, 1 week ago